Outcome of specific bronchial responsiveness to occupational agents after removal from exposure

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 2, 1996, Pages 329-333

  Lemiere C ^b   Cartier, A ^b   Dolovich, J ^b   Chan Yeung, M ^b   Grammer, L ^b   Ghezzo, H ^b   L'archeveque J ^b   Malo, J L ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; ISOCYANATE; SERUM ALBUMIN;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOREACTIVITY; MALE; OCCUPATIONAL ASTHMA; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RADIOALLERGOSORBENT TEST; RISK FACTOR; SPIROMETRY; STATISTICAL ANALYSIS;

EID: 0029737467     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.2.8756802     Document Type: Article

References (22)

1. Chan-Yeung, M., and J. L. Malo. 1993. Natural history of occupational asthma. In I. L. Bernstein, M. Chan-Yeung, J. L. Malo, and D. I. Bernstein, editors. Asthma in the Workplace. Marcel Dekker, New York. 299-322.
2. Butcher, B. T., C. E. O'Neil, M. A. Reed, J. E. Salvaggio, and H. Weill. 1982. Development and loss of toluene diisocyanate reactivity: immunologic, pharmacologic,and provocative challenge studies. J. Allergy Clin. Immunol. 70:231-235.
3. Mapp, C. E., P. C. Corona, N. de Marxo, and L. Fabbri. 1988. Persistent asthma due to isocyanates. A follow-up study of subjects with occupational asthma asthma due to toluene diisocyanate. Am. Rev. Respir. Dis. 137:1326-1329.
4. Saetta, M., P. Maestrelli, G. Turato, C. E. Mapp, G. Milani, F. Pivirotto, L. M. Fabbri, and A. DiStefano. 1995. Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am. J. Respir. Crit. Care Med. 151:489-494.
5. Cloutier, Y., F. Lagier, R. Lemieux, M. C. Blais, C. St-Arnaud, A. Cartier, and J. L. Malo. 1989. New methodology for specific inhalation challenges with occupational agents in powder form. Eur. Respir. J. 2:769-777.
6. Vandenplas, O., J. L. Malo, A. Cartier, G. Perreault, and Y. Cloutier. 1992. Closed-circuit methodology for inhalation challenge test with isocyanates. Am. Rev. Respir. Dis. 145:582-587.
7. Cartier, A. 1994. Definition and diagnosis of occupational asthma. Eur. Respir. J. 7:153-160.
8. American Thoracic Society. 1987. Standardization of spirometry - 1987 update. Am. Rev. Respir. Dis. 136:1285-1307.
9. Cockcroft, D. W., D. N. Killian, J. J. A. Mellon, and F. E. Hargreave. 1977. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin. Allergy 7:235-243.
10. Cartier, A., L. Grammer, J. L. Malo, F. Lagier, H. Ghezzo, K. Harris, and R. Patterson. 1989. Specific serum antibodies against isocyanates: association with occupational asthma. J. Allergy Clin. Immunol. 84:507-514.
11. Lagier, F., A. Cartier, J. Somer, J. Dolovich, and J. L. Malo. 1990. Occupational asthma caused by guar gum. J. Allergy Clin. Immunol. 85:785-790.
12. Bardy, J. D., J. L. Malo, P. Séguin, H. Ghezzo, J. Desjardins, J. Dolovich, and A. Cartier. 1987. Occupational asthma and IgE sensitization in a pharmaceutical company processing psyllium. Am. Rev. Respir. Dis. 135:1033-1038.
13. Knudson, R. J., M. D. Lebowitz, C. J. Holberg, and B. Burrows. 1983. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am. Rev. Respir. Dis. 127:725-734.
14. Dehaut, P., A. Rachiele, R. R. Martin, and J. L. Malo. 1983. Histamine dose-response curves in asthma: reproducibility and sensitivity of different indices to assess response. Thorax 38:516-522.
15. National Institutes of Health. National Heart, Lung and Blood Institute 1992. International consensus report on diagnosis and treatment of asthma. Eur. Respir. J. 5:601-641.
16. Merget, R., M. Reineke, A. Rueckmann, E. M. Bergmann, and G. Schultze-Werninghaus. 1994. Nonspecific and specific bronchial responsiveness in occupational asthma caused by plantinum salts after allergen avoidance. Am. J. Respir. Crit. Care Med. 150:1146-1149.
17. Vandenplas, O., A. Cartier, H. Ghezzo, Y. Cloutier, and J. L. Malo. 1993. Response to isocyanates: effect of concentration, duration of exposure, and dose. Am. Rev. Respir. Dis. 147:1287-1290.
18. Cockcroft, D. W., R. E. Ruffin, P. A. Frith, A. Cartier, E. F. Juniper, J. Dolovich, and F. E. Hargreave. 1979. Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine. Am. Rev. Respir. Dis. 120:1053-1058.
19. Venables, K. M., M. D. Topping, A. J. Nunn, W. Howe, and A. J. Newman-Taylor. 1987. Immunologic and functional consequences of chemical (tetracholorophthalic anhydride)-induced asthma after four years of avoidance of exposure. J. Allergy Clin. Immunol. 80:212-218.
20. Malo, J. L., A. Cartier, H. Ghezzo, M. Lafrance, M. Mccants, and S. B. Lehrer. 1988. Patterns of improvement of spirometry, bronchial hyperresponsiveness, and specific IgE antibody levels after cessation of exposure in occupational asthma caused by snow-crab processing. Am. Rev. Respir. Dis. 138:807-812.
21. Cartier, A., and J. L. Malo. 1993. Occupational challenge tests. In I. L. Bernstein, M. Chan-Yeung, J. L. Malo, and D. I. Bernstein, editors. Asthma in the Workplace. Marcel Dekker, New York, 215-247.
22. Chan-Yeung, M., and J. L. Malo. 1995. Occupational asthma. N. Engl. J. Med. 333:107-112.